NFE2L2 and hepatocellular carcinoma: Likewise, treatment with the mitochondrial Ca2+-buffering protein parvalbumin significantly inhibited ROS/Nrf-2/Notch pathway and MCUR1-induced EMT and HCC metastasis [255].